BIOATLA, INC. (BCAB) Dividend Safety
- Dividend payout ratio · 12 months: Value (m); Formula and calculation Cash dividends paid / net income. Period ending 2026-06-30..
Dividend safety
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Dividend payout ratio · 12 months | (m) | Cash dividends paid / net income. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Dividend payments · 12 months | (m) | |
| Net income · 12 months | 87.75M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Dividend payments · 12 months (USD) | Net income · 12 months (USD) | Dividend payout |
|---|---|---|---|
| 2026-06-30 | (m) | $87.75M | (m) |
| 2026-03-31 | (m) | $-50.62M | (m) |
| 2025-12-31 | (m) | $-59.61M | (m) |
| 2025-09-30 | (m) | $-64.71M | (m) |
| 2025-06-30 | (m) | $-59.52M | (m) |
| 2025-03-31 | (m) | $-61.88M | (m) |
| 2024-12-31 | (m) | $-69.78M | (m) |
| 2024-09-30 | (m) | $-81.82M | (m) |
| 2024-06-30 | (m) | $-104.56M | (m) |
| 2024-03-31 | (m) | $-119.24M | (m) |
| 2023-12-31 | (m) | $-123.46M | (m) |
| 2023-09-30 | (m) | $-124.08M | (m) |
| 2023-06-30 | (m) | $-116.53M | (m) |
| 2023-03-31 | (m) | $-109.69M | (m) |
| 2022-12-31 | (m) | $-106.48M | (m) |
| 2022-09-30 | (m) | $-102.33M | (m) |
| 2022-06-30 | (m) | $-99.48M | (m) |
| 2022-03-31 | (m) | $-100.95M | (m) |
| 2021-12-31 | (m) | $-95.40M | (m) |
| 2021-09-30 | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) |
| 2020-12-31 | (m) | $-35.85M | (m) |
| 2020-09-30 | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) |
| 2019-12-31 | (m) | $-29.86M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |